![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print January 4, 2002
Molecular Oncology Program, MRC 3-East, H. Lee Moffitt Cancer Center and Research Institute,, Tampa, FL 33612
Corresponding Author: wu{at}moffitt.usf.edu
Gab1-SHP2 association is required for Erk mitogen-activated protein (MAP) kinase activation by several growth factors. Gab1-SHP2 interaction activates SHP2. However, an activated SHP2 still needs to associate with Gab1 to mediate Erk activation. It was unclear whether SHP2 is required to dephosphorylate a negative phosphorylation site on Gab1 or whether SHP2 needs the Gab1 pleckstrin homology (PH) domain to target it to the plasma membrane. We found that expression of a fusion protein consisting of the Gab1 PH domain and an active SHP2 (Gab1PH-SHP2dN) induced constitutive Mek1 and Erk2 activation. Linking the active SHP2dN to the PDK1 PH domain or the FRS2 myristoylation sequence also induced Mek1 activation. Mek1 activation by Gab1PH-SHP2dN was inhibited by a Src inhibitor and by Csk. Significantly, Gab1PH-SHP2dN induced Src activation. Gab1PH-SHP2dN expression activated Ras and the Gab1PH-SHP2dN-induced Mek1 activation was blocked by RasN17. These findings suggest that Gab1PH-SHP2dN activated a signaling step upstream of Src and Ras. The SHP2 tyrosine phosphatase activity is essential for the function of the fusion protein. Together, these data show that Gab1 sequence besides the PH domain and SHP2 binding sites is dispensable for Erk activation, suggesting that the primary role of Gab1 association with an activated SHP2 is to target it to the membrane.
J. Biol. Chem, 10.1074/jbc.M110547200
Submitted on November 2, 2001
Revised on January 4, 2002
Accepted on January 4, 2002
Regulation of the mitogen-activated protein kinase signaling pathway by SHP2
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
K. Hellmuth, S. Grosskopf, C. T. Lum, M. Wurtele, N. Roder, J. P. von Kries, M. Rosario, J. Rademann, and W. Birchmeier Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking PNAS, May 20, 2008; 105(20): 7275 - 7280. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Seiden-Long, R. Navab, W. Shih, M. Li, J. Chow, C. Q. Zhu, N. Radulovich, C. Saucier, and M.-S. Tsao Gab1 but not Grb2 mediates tumor progression in Met overexpressing colorectal cancer cells Carcinogenesis, March 1, 2008; 29(3): 647 - 655. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Shahjahan Miah, T. L. Hughes, and K. S. Campbell KIR2DL4 Differentially Signals Downstream Functions in Human NK Cells through Distinct Structural Modules J. Immunol., March 1, 2008; 180(5): 2922 - 2932. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ren, Z. Chen, L. Chen, N. T. Woods, G. W. Reuther, J. Q. Cheng, H.-g. Wang, and J. Wu Shp2E76K Mutant Confers Cytokine-independent Survival of TF-1 Myeloid Cells by Up-regulating Bcl-XL J. Biol. Chem., December 14, 2007; 282(50): 36463 - 36473. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-B. Guo, M. Randolph, and M. Pierce Inhibition of a Specific N-Glycosylation Activity Results in Attenuation of Breast Carcinoma Cell Invasiveness-related Phenotypes: INHIBITION OF EPIDERMAL GROWTH FACTOR-INDUCED DEPHOSPHORYLATION OF FOCAL ADHESION KINASE J. Biol. Chem., July 27, 2007; 282(30): 22150 - 22162. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Y. Tan, C. L. Richard, H. Zhang, D. W. Hoskin, and J. Blay Adenosine downregulates DPPIV on HT-29 colon cancer cells by stimulating protein tyrosine phosphatase(s) and reducing ERK1/2 activity via a novel pathway Am J Physiol Cell Physiol, September 1, 2006; 291(3): C433 - C444. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mood, C. Saucier, Y.-S. Bong, H.-S. Lee, M. Park, and I. O. Daar Gab1 Is Required for Cell Cycle Transition, Cell Proliferation, and Transformation Induced by an Oncogenic Met Receptor Mol. Biol. Cell, September 1, 2006; 17(9): 3717 - 3728. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chen, S.-S. Sung, M. L. R. Yip, H. R. Lawrence, Y. Ren, W. C. Guida, S. M. Sebti, N. J. Lawrence, and J. Wu Discovery of a Novel Shp2 Protein Tyrosine Phosphatase Inhibitor Mol. Pharmacol., August 1, 2006; 70(2): 562 - 570. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Chen, F. Y. Lee, K. N. Bhalla, and J. Wu Potent Inhibition of Platelet-Derived Growth Factor-Induced Responses in Vascular Smooth Muscle Cells by BMS-354825 (Dasatinib) Mol. Pharmacol., May 1, 2006; 69(5): 1527 - 1533. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhao, S. Hart, J. Cheng, J. J. Melenhorst, B. Bierie, M. Ernst, C. Stewart, F. Schaper, P. C. Heinrich, A. Ullrich, et al. Mammary Gland Remodeling Depends on gp130 Signaling through Stat3 and MAPK J. Biol. Chem., October 15, 2004; 279(42): 44093 - 44100. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Miquet, A. I. Sotelo, A. Bartke, and D. Turyn Suppression of Growth Hormone (GH) Janus Tyrosine Kinase 2/Signal Transducer and Activator of Transcription 5 Signaling Pathway in Transgenic Mice Overexpressing Bovine GH Endocrinology, June 1, 2004; 145(6): 2824 - 2832. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hanafusa, S. Torii, T. Yasunaga, K. Matsumoto, and E. Nishida Shp2, an SH2-containing Protein-tyrosine Phosphatase, Positively Regulates Receptor Tyrosine Kinase Signaling by Dephosphorylating and Inactivating the Inhibitor Sprouty J. Biol. Chem., May 28, 2004; 279(22): 22992 - 22995. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kallin, J.-B. Demoulin, K. Nishida, T. Hirano, L. Ronnstrand, and C.-H. Heldin Gab1 Contributes to Cytoskeletal Reorganization and Chemotaxis in Response to Platelet-derived Growth Factor J. Biol. Chem., April 23, 2004; 279(17): 17897 - 17904. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bayle, S. Letard, R. Frank, P. Dubreuil, and P. De Sepulveda Suppressor of Cytokine Signaling 6 Associates with KIT and Regulates KIT Receptor Signaling J. Biol. Chem., March 26, 2004; 279(13): 12249 - 12259. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ren, S. Meng, L. Mei, Z. J. Zhao, R. Jove, and J. Wu Roles of Gab1 and SHP2 in Paxillin Tyrosine Dephosphorylation and Src Activation in Response to Epidermal Growth Factor J. Biol. Chem., February 27, 2004; 279(9): 8497 - 8505. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Kapoor, Y. Zhan, G. R. Johnson, and D. M. O'Rourke Distinct Domains in the SHP-2 Phosphatase Differentially Regulate Epidermal Growth Factor Receptor/NF-{kappa}B Activation through Gab1 in Glioblastoma Cells Mol. Cell. Biol., January 15, 2004; 24(2): 823 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dixit, D. Zhuang, B. Ceacareanu, and A. Hassid Treatment With Insulin Uncovers the Motogenic Capacity of Nitric Oxide in Aortic Smooth Muscle Cells: Dependence on Gab1 and Gab1-SHP2 Association Circ. Res., November 14, 2003; 93 (10): e113 - e123. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ling, L. A. Maile, and D. R. Clemmons Tyrosine Phosphorylation of the {beta}3-Subunit of the {alpha}V{beta}3 Integrin Is Required for Membrane Association of the Tyrosine Phosphatase SHP-2 and Its Further Recruitment to the Insulin-Like Growth Factor I Receptor Mol. Endocrinol., September 1, 2003; 17(9): 1824 - 1833. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. MacGillivray, M. T. Herrera-Abreu, C.-W. Chow, C. Shek, Q. Wang, E. Vachon, G.-S. Feng, K. A. Siminovitch, C. A. G. McCulloch, and G. P. Downey The Protein Tyrosine Phosphatase SHP-2 Regulates Interleukin-1-induced ERK Activation in Fibroblasts J. Biol. Chem., July 11, 2003; 278(29): 27190 - 27198. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gao, W. Sun, M. Christofidou-Solomidou, M. Sawada, D. K. Newman, C. Bergom, S. M. Albelda, S. Matsuyama, and P. J. Newman PECAM-1 functions as a specific and potent inhibitor of mitochondrial-dependent apoptosis Blood, July 1, 2003; 102(1): 169 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-O. Kim, K. Loesch, X. Wang, J. Jiang, L. Mei, J. M. Cunnick, J. Wu, and S. J. Frank A Role for Grb2-Associated Binder-1 in Growth Hormone Signaling Endocrinology, December 1, 2002; 143(12): 4856 - 4867. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Maile and D. R. Clemmons The {alpha}V{beta}3 Integrin Regulates Insulin-Like Growth Factor I (IGF-I) Receptor Phosphorylation by Altering the Rate of Recruitment of the Src-Homology 2-Containing Phosphotyrosine Phosphatase-2 to the Activated IGF-I Receptor Endocrinology, November 1, 2002; 143(11): 4259 - 4264. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Cai, K. Nishida, T. Hirano, and P. A. Khavari Gab1 and SHP-2 promote Ras/MAPK regulation of epidermal growth and differentiation J. Cell Biol., October 14, 2002; 159(1): 103 - 112. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |